CCN3 and neoplasm: CCN3 has anti-tumor effects in breast cancer (Dobson et al., 2014), colorectal tumors (Li et al., 2017), kidney cancer (Liu et al., 2012), glioma (Gupta et al., 2001), and leukemia (McCallum et al., 2012).